Barriers to antiretroviral therapy adherence in rural Mozambique
- Scaling up stigma? The effects of antiretroviral roll-out on stigma and HIV testing. Early evidence from rural Tanzania. Roura, M.; Urassa, M.; Busza, J.; Mbata, D.; Wringe, A.; Zaba, B. // Sexually Transmitted Infections;Aug2009, Vol. 85 Issue 4, p18
Objective: To investigate the interplay between antiretroviral therapy (ART) scale-up, different types of stigma and Voluntary Counselling and Testing (VCT) uptake 2 years after the introduction of free ART in a rural ward of Tanzania. Methods: Qualitative study using in-depth interviews and...
- The impact of highly active antiretroviral therapy on high-risk behaviour of HIV-infected patients in sub-Saharan Africa. Kabonge Kaye, Dan; Kakaire, Othman; Odongo Osinde, Michael; Chrysotom Lule, John; Kakande, Nelson // Journal of Infection in Developing Countries;Jun2013, Vol. 7 Issue 6, p436
Introduction: High-risk sexual behaviors such as multiple sexual partners, inconsistent condom use, acquisition of sexually transmitted infection (STIs), and non-use of contraceptives persist in HIV patients undergoing care. We conducted a systematic review of studies conducted in the era of...
- Does HAART Efficacy Translate to Effectiveness? Evidence for a Trial Effect Menezes, Prema; Miller, William C.; Wohl, David A.; Adimora, Adaora A.; Leone, Peter A.; Eron Jr., Joseph J. // PLoS Clinical Trials;Jul2011, Vol. 6 Issue 7, p1
Background: Patients who participate in clinical trials may experience better clinical outcomes than patients who initiate similar therapy within clinical care (trial effect), but no published studies have evaluated a trial effect in HIV clinical trials. Methods: To examine a trial effect...
- Incidence and Associated Factors of HIV Drug Resistance in Chinese HIV-Infected Patients Receiving Antiretroviral Treatment. Xing, Hui; Wang, Xia; Liao, Lingjie; Ma, Yanling; Su, Bin; Fu, Jihua; He, Jianmei; Chen, Lin; Pan, Xiaohong; Dong, Yonghui; Liu, Wei; Hsi, Jenny H.; Yang, Liting; Ruan, Yuhua; Shao, Yiming // PLoS ONE;Apr2013, Vol. 8 Issue 4, p1
Background: A critical indicator of the future success of highly active antiretroviral therapy (HAART) is the incidence of HIV drug resistance, which has not been studied in China on the national scale. Methods: HIV drug resistance baseline survey was conducted in the eight provinces with the...
- A Comparison of HAART Outcomes between the US Military HIV Natural History Study (NHS) and HIV Atlanta Veterans Affairs Cohort Study (HAVACS) Guest, Jodie L.; Weintrob, Amy C.; Rimland, David; Rentsch, Christopher; Bradley, William P.; Agan, Brian K.; Marconi, Vincent C.; Group, IDCRPHIV Working // PLoS ONE;May2013, Vol. 8 Issue 5, p1
Introduction: The Department of Defense (DoD) and the Department of Veterans Affairs (VA) provide comprehensive HIV treatment and care to their beneficiaries with open access and few costs to the patient. Individuals who receive HIV care in the VA have higher rates of substance abuse,...
- Annals of Internal Medicine: HIV treatment use increases in the US. // Biomedical Market Newsletter;8/28/2012, Vol. 21, p1
The article informs that the usage of highly active antiretroviral therapy for the treatment of Human Immunodeficiency Virus (HIV)-infection has increased in the U.S.
- The dual CCR5 and CCR2 inhibitor cenicriviroc does not redistribute HIV into extracellular space: implications for plasma viral load and intracellular DNA decline. Kramer, Victor G.; Hassounah, Said; Colby-Germinario, Susan P.; Oliveira, Maureen; Lefebvre, Eric; Mesplède, Thibault; Wainberg, Mark A. // Journal of Antimicrobial Chemotherapy (JAC);Mar2015, Vol. 70 Issue 3, p750
Objectives Cenicriviroc is a potent antagonist of the chemokine coreceptors 5 and 2 (CCR5/CCR2) and blocks HIV-1 entry. The CCR5 inhibitor maraviroc has been shown in tissue culture to be able to repel cell-free virions from the cell surface into extracellular space. We hypothesized that...
- Combination ART may not completely inhibit viral replication, block sexual transmission. // Infectious Disease News;Sep2011, Vol. 24 Issue 9, p44
The article discusses a research study which suggested the incapacity of combination genital tract drug concentrations and antiretroviral therapy (ART) to completely inhibit local viral replication and to block sexual transmission.
- Correction. // American Family Physician;7/15/2011, Vol. 84 Issue 2, p154
A correction to the article "Common Adverse Effects of Antiretroviral Therapy for HIV Disease," which appeared in the Juny 15, 2011 issue is presented.